ÂÜÀòÂÒÂ×

Rick Heinick is an experienced professional in the biotechnology sector, serving as the Chairman of SLAM BioTherapeutics and holding various board positions at TearClear, UltraSight, NanoDrops, and LENTECHS. As the Founder and a member of the Board of Directors at TearClear, Rick has contributed significantly to the growth of innovative healthcare solutions. Rick's educational background includes a degree from Boston University (1983 - 1987) and further studies at McGill University (2007 - 2009).